Targeted next-generation sequencing panels in the diagnosis of Charcot-Marie-Tooth disease is organized by American Academy of Neurology (AAN).
Dates:
Released: 1/17/2020
Expires: 1/07/2023
Learning Objectives:
Upon completion of this podcast, participants will be able to understand that first ruling out PMP22 duplication/deletion, then considering a targeted genetic testing approach as outlined, in selected patients will increase diagnostic yield in Charcot-Marie-Tooth disease.
Copyrights © 2026 eMedEvents Corporation, All Rights Reserved